LTZ Therapeutics is a global biotech company focused on immunotherapy, developing innovative treatments for oncology and autoimmune diseases. Its pioneering myeloid engager platform leverages macrophages to improve patient outcomes, with the bold goal of eliminating cancer.
LTZ Therapeutics Highlights:
Overview
- Website: ltztherapeutics.com
- Headquarters: Redwood City, California
- Employees: 33
- Founded: 2022
- Email: info@ltztherapeutics.com
- Funding: $27.0M
- Revenue: $2.6M
- Valuation: n/a
Contacts
- Email: ***@ltztherapeutics.com
Similar companies
Frequently Asked Questions related to LTZ Therapeutics
LTZ Therapeutics is located in Redwood City, California.
Yes, LTZ Therapeutics is a Silicon Valley company.
LTZ Therapeutics total funding is 27.0M.
LTZ Therapeutics revenue is 2.6M.
LTZ Therapeutics’s number of employees is 33.
LTZ Therapeutics’s CEO name is Robert Li.
LTZ Therapeutics was founded in 2022.
LTZ Therapeutics’s contact email is info@ltztherapeutics.com.
